T13	B-Entity	0	7	Epstein	Epstein	B-NP	NNP	O	7	NMOD	O
T13	I-Entity	7	8	-	-	I-NP	HYPH	O	7	NMOD	O
T13	I-Entity	8	12	Barr	Barr	I-NP	NNP	O	7	NMOD	O
T13	I-Entity	13	18	virus	virus	I-NP	NN	O	7	NMOD	O
T13	I-Entity	19	30	replicative	replicative	I-NP	JJ	O	7	NMOD	O
T13	I-Entity	31	35	gene	gene	I-NP	NN	O	7	NMOD	O
O	O	36	49	transcription	transcription	I-NP	NN	O	18	NMOD	O
O	O	50	56	during	during	B-PP	IN	O	7	NMOD	O
O	O	57	59	de	de	B-NP	FW	O	10	AMOD	O
O	O	60	64	novo	novo	I-NP	FW	O	11	NMOD	O
O	O	65	74	infection	infection	I-NP	NN	O	8	PMOD	O
O	O	75	77	of	of	B-PP	IN	O	11	NMOD	O
O	O	78	83	human	human	B-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	84	94	thymocytes	thymocyte	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
O	O	94	95	:	:	O	:	O	7	P	O
O	O	96	108	simultaneous	simultaneous	B-NP	JJ	O	18	NMOD	O
O	O	109	114	early	early	I-NP	JJ	O	18	NMOD	O
O	O	115	125	expression	expression	I-NP	NN	O	0	ROOT	O
O	O	126	128	of	of	B-PP	IN	O	18	NMOD	O
T1	B-Protein	129	133	BZLF	BZLF	B-NP	NN	B-protein	21	NMOD	B-protein
T1	I-Protein	133	134	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
T1	I-Protein	134	135	1	1	I-NP	CD	I-protein	21	NMOD	I-protein
O	O	136	139	and	and	O	CC	O	26	NMOD	O
O	O	140	143	its	its	B-NP	PRP$	O	26	NMOD	O
O	O	144	153	repressor	repressor	I-NP	NN	O	26	NMOD	O
T2	B-Protein	154	157	RAZ	RAZ	I-NP	NN	B-protein	19	PMOD	B-protein
O	O	157	158	.	.	O	.	O	18	P	O

O	O	160	167	Epstein	Epstein	B-NP	NNP	O	8	SUB	O
O	O	167	168	-	-	I-NP	HYPH	O	1	NMOD	O
O	O	168	172	Barr	Barr	I-NP	NNP	O	4	NMOD	O
O	O	173	178	virus	virus	I-NP	NN	O	2	OBJ	O
O	O	179	180	(	(	O	(	O	7	DEP	O
O	O	180	183	EBV	EBV	B-NP	NN	O	7	DEP	O
O	O	183	184	)	)	O	)	O	4	NMOD	O
O	O	185	187	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	188	193	known	know	I-VP	VBN	O	8	VC	O
O	O	194	196	to	to	I-VP	TO	O	11	VMOD	O
O	O	197	203	infect	infect	I-VP	VB	O	9	VMOD	O
O	O	204	205	B	B	B-NP	NN	B-cell_type	13	NMOD	B-cell_type
O	O	206	211	cells	cell	I-NP	NNS	I-cell_type	16	NMOD	I-cell_type
O	O	212	215	and	and	O	CC	O	16	NMOD	O
O	O	216	226	epithelial	epithelial	B-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	227	232	cells	cell	I-NP	NNS	I-cell_type	11	OBJ	I-cell_type
O	O	232	233	.	.	O	.	O	8	P	O

O	O	234	236	We	We	B-NP	PRP	O	3	NMOD	O
O	O	237	240	and	and	O	CC	O	3	NMOD	O
O	O	241	247	others	other	B-NP	NNS	O	4	SUB	O
O	O	248	252	have	have	B-VP	VBP	O	0	ROOT	O
O	O	253	258	shown	show	I-VP	VBN	O	4	VC	O
O	O	259	263	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	264	267	EBV	EBV	B-NP	NN	O	8	SUB	O
O	O	268	271	can	can	B-VP	MD	O	6	SBAR	O
O	O	272	276	also	also	I-VP	RB	O	8	VMOD	O
O	O	277	283	infect	infect	I-VP	VB	O	8	VC	O
O	O	284	285	a	a	B-NP	DT	O	12	NMOD	O
O	O	286	292	subset	subset	I-NP	NN	O	10	OBJ	O
O	O	293	295	of	of	B-PP	IN	O	12	NMOD	O
O	O	296	306	thymocytes	thymocyte	B-NP	NNS	B-cell_type	13	PMOD	B-cell_type
O	O	306	307	.	.	O	.	O	4	P	O

O	O	308	317	Infection	Infection	B-NP	NN	O	4	SUB	O
O	O	318	320	of	of	B-PP	IN	O	1	NMOD	O
O	O	321	331	thymocytes	thymocyte	B-NP	NNS	B-cell_type	2	PMOD	B-cell_type
O	O	332	335	was	be	B-VP	VBD	O	0	ROOT	O
O	O	336	347	accompanied	accompany	I-VP	VBN	O	4	VC	O
O	O	348	350	by	by	B-PP	IN	O	5	VMOD	O
O	O	351	354	the	the	B-NP	DT	O	8	NMOD	O
O	O	355	365	appearance	appearance	I-NP	NN	O	6	PMOD	O
O	O	366	368	of	of	B-PP	IN	O	8	NMOD	O
T14	B-Entity	369	375	linear	linear	B-NP	JJ	B-DNA	12	NMOD	B-DNA
T14	I-Entity	376	379	EBV	EBV	I-NP	NN	I-DNA	12	NMOD	I-DNA
T14	I-Entity	380	386	genome	genome	I-NP	NN	I-DNA	9	PMOD	I-DNA
O	O	387	393	within	within	B-PP	IN	O	8	NMOD	O
O	O	394	395	8	8	B-NP	CD	O	15	NMOD	O
O	O	396	398	hr	hr	I-NP	NN	O	13	PMOD	O
O	O	399	401	of	of	B-PP	IN	O	15	NMOD	O
O	O	402	411	infection	infection	B-NP	NN	O	16	PMOD	O
O	O	411	412	.	.	O	.	O	4	P	O

O	O	413	428	Circularization	Circularization	B-NP	NN	O	6	SUB	O
O	O	429	431	of	of	B-PP	IN	O	1	NMOD	O
O	O	432	435	the	the	B-NP	DT	O	5	NMOD	O
T15	B-Entity	436	439	EBV	EBV	I-NP	NN	B-DNA	5	NMOD	B-DNA
T15	I-Entity	440	446	genome	genome	I-NP	NN	I-DNA	2	PMOD	I-DNA
O	O	447	450	was	be	B-VP	VBD	O	0	ROOT	O
O	O	451	454	not	not	I-VP	RB	O	6	VMOD	O
O	O	455	463	detected	detect	I-VP	VBN	O	6	VC	O
O	O	463	464	.	.	O	.	O	6	P	O

O	O	465	469	This	This	B-NP	DT	O	2	SUB	O
O	O	470	472	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	473	475	in	in	B-PP	IN	O	2	PRD	O
O	O	476	484	contrast	contrast	B-NP	NN	O	3	PMOD	O
O	O	485	487	to	to	B-PP	TO	O	4	NMOD	O
O	O	488	491	the	the	B-NP	DT	O	7	NMOD	O
O	O	492	501	infection	infection	I-NP	NN	O	5	PMOD	O
O	O	502	504	in	in	B-PP	IN	O	7	NMOD	O
O	O	505	506	B	B	B-NP	NN	B-cell_type	10	NMOD	B-cell_type
O	O	507	512	cells	cell	I-NP	NNS	I-cell_type	8	PMOD	I-cell_type
O	O	513	518	where	where	B-ADVP	WRB	O	10	NMOD	O
O	O	519	522	the	the	B-NP	DT	O	13	NMOD	O
O	O	523	529	genome	genome	I-NP	NN	O	14	SUB	O
O	O	530	533	can	can	B-VP	MD	O	11	SBAR	O
O	O	534	545	circularize	circularize	I-VP	VB	O	14	VC	O
O	O	546	552	within	within	B-PP	IN	O	15	VMOD	O
O	O	553	555	24	24	B-NP	CD	O	18	NMOD	O
O	O	556	558	hr	hr	I-NP	NN	O	16	PMOD	O
O	O	559	561	of	of	B-PP	IN	O	18	NMOD	O
O	O	562	571	infection	infection	B-NP	NN	O	19	PMOD	O
O	O	571	572	.	.	O	.	O	2	P	O

O	O	573	576	The	The	B-NP	DT	O	2	NMOD	O
O	O	577	587	appearance	appearance	I-NP	NN	O	19	SUB	O
O	O	588	590	of	of	B-PP	IN	O	2	NMOD	O
O	O	591	594	the	the	B-NP	DT	O	10	NMOD	O
T3	B-Protein	595	600	BamHI	BamHI	I-NP	NN	B-protein	10	NMOD	B-protein
T3	I-Protein	601	604	ZLF	ZLF	I-NP	NN	I-protein	10	NMOD	I-protein
T3	I-Protein	604	605	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T3	I-Protein	605	606	1	1	I-NP	CD	I-protein	10	NMOD	I-protein
O	O	607	611	gene	gene	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	612	619	product	product	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	619	620	,	,	O	,	O	12	P	O
T4	B-Protein	621	626	ZEBRA	ZEBRA	B-NP	NN	B-protein	3	PMOD	B-protein
O	O	626	627	,	,	O	,	O	2	P	O
O	O	628	630	by	by	B-PP	IN	O	2	NMOD	O
O	O	631	633	RT	RT	B-NP	NN	O	17	NMOD	O
O	O	633	634	-	-	B-NP	HYPH	O	17	NMOD	O
O	O	634	637	PCR	PCR	I-NP	NN	O	14	PMOD	O
O	O	637	638	,	,	O	,	O	2	P	O
O	O	639	642	was	be	B-VP	VBD	O	0	ROOT	O
O	O	643	651	observed	observe	I-VP	VBN	O	19	VC	O
O	O	652	658	within	within	B-PP	IN	O	20	VMOD	O
O	O	659	660	8	8	B-NP	CD	O	23	NMOD	O
O	O	661	663	hr	hr	I-NP	NN	O	21	PMOD	O
O	O	664	666	of	of	B-PP	IN	O	23	NMOD	O
O	O	667	676	infection	infection	B-NP	NN	O	24	PMOD	O
O	O	676	677	.	.	O	.	O	19	P	O

O	O	678	681	The	The	B-NP	DT	O	2	NMOD	O
O	O	682	692	appearance	appearance	I-NP	NN	O	29	SUB	O
O	O	693	695	of	of	B-PP	IN	O	2	NMOD	O
O	O	696	697	a	a	B-NP	DT	O	7	NMOD	O
O	O	698	703	novel	novel	I-NP	JJ	O	7	NMOD	O
O	O	704	710	fusion	fusion	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	711	721	transcript	transcript	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	722	723	(	(	O	(	O	10	DEP	O
T5	B-Protein	723	726	RAZ	RAZ	B-NP	NN	B-protein	10	DEP	B-protein
O	O	726	727	)	)	O	)	O	7	NMOD	O
O	O	727	728	,	,	O	,	O	2	P	O
O	O	729	734	which	which	B-NP	WDT	O	2	NMOD	O
O	O	735	744	comprised	comprise	B-VP	VBD	O	12	SBAR	O
O	O	745	752	regions	region	B-NP	NNS	O	27	NMOD	O
O	O	753	755	of	of	B-PP	IN	O	14	NMOD	O
O	O	756	759	the	the	B-NP	DT	O	20	NMOD	O
T6	B-Protein	760	764	BZLF	BZLF	I-NP	NN	B-DNA	20	NMOD	B-DNA
T6	I-Protein	764	765	-	-	B-NP	HYPH	I-DNA	20	NMOD	I-DNA
T6	I-Protein	765	766	1	1	I-NP	CD	I-DNA	20	NMOD	I-DNA
T16	B-Entity	767	772	locus	locus	I-NP	NN	I-DNA	15	PMOD	I-DNA
O	O	773	776	and	and	O	CC	O	27	NMOD	O
O	O	777	780	the	the	B-NP	DT	O	23	NMOD	O
O	O	781	789	adjacent	adjacent	I-NP	JJ	O	27	NMOD	O
T7	B-Protein	790	794	BRLF	BRLF	I-NP	NN	B-DNA	27	NMOD	B-DNA
T7	I-Protein	794	795	-	-	B-NP	HYPH	I-DNA	27	NMOD	I-DNA
T7	I-Protein	795	796	1	1	I-NP	CD	I-DNA	27	NMOD	I-DNA
T17	B-Entity	797	802	locus	locus	I-NP	NN	I-DNA	13	OBJ	I-DNA
O	O	802	803	,	,	O	,	O	2	P	O
O	O	804	807	was	be	B-VP	VBD	O	0	ROOT	O
O	O	808	816	detected	detect	I-VP	VBN	O	29	VC	O
O	O	817	819	by	by	B-PP	IN	O	30	VMOD	O
O	O	820	822	RT	RT	B-NP	NN	O	34	NMOD	O
O	O	822	823	-	-	B-NP	HYPH	O	34	NMOD	O
O	O	823	826	PCR	PCR	I-NP	NN	O	31	PMOD	O
O	O	826	827	.	.	O	.	O	29	P	O

T8	B-Protein	828	833	ZEBRA	ZEBRA	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	834	841	protein	protein	I-NP	NN	I-protein	3	SUB	I-protein
O	O	842	845	was	be	B-VP	VBD	O	0	ROOT	O
O	O	846	850	also	also	I-VP	RB	O	3	VMOD	O
O	O	851	861	identified	identify	I-VP	VBN	O	3	VC	O
O	O	862	864	in	in	B-PP	IN	O	5	VMOD	O
O	O	865	873	infected	infected	B-NP	JJ	O	6	PMOD	O
O	O	874	884	thymocytes	thymocyte	I-NP	NNS	B-cell_type	7	NMOD	B-cell_type
O	O	885	887	by	by	B-PP	IN	O	5	VMOD	O
O	O	888	907	immunoprecipitation	immunoprecipitation	B-NP	NN	O	9	PMOD	O
O	O	907	908	.	.	O	.	O	3	P	O

O	O	909	911	In	In	B-PP	IN	O	5	VMOD	O
O	O	912	920	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	920	921	,	,	O	,	O	5	P	O
O	O	922	924	we	we	B-NP	PRP	O	5	SUB	O
O	O	925	937	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	938	942	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	943	946	the	the	B-NP	DT	O	11	NMOD	O
T9	B-Protein	947	951	EBNA	EBNA	I-NP	NN	B-DNA	11	NMOD	B-DNA
T9	I-Protein	951	952	-	-	B-NP	HYPH	I-DNA	11	NMOD	I-DNA
T9	I-Protein	952	953	1	1	I-NP	CD	I-DNA	11	NMOD	I-DNA
O	O	954	958	gene	gene	I-NP	NN	I-DNA	15	SUB	I-DNA
O	O	959	961	in	in	B-PP	IN	O	11	NMOD	O
O	O	962	970	infected	infected	B-NP	JJ	O	12	PMOD	O
O	O	971	981	thymocytes	thymocyte	I-NP	NNS	B-cell_type	13	NMOD	B-cell_type
O	O	982	985	was	be	B-VP	VBD	O	6	SBAR	O
O	O	986	997	transcribed	transcribe	I-VP	VBN	O	15	VC	O
O	O	998	1002	from	from	B-PP	IN	O	16	VMOD	O
O	O	1003	1006	the	the	B-NP	DT	O	20	NMOD	O
T18	B-Entity	1007	1009	Fp	Fp	I-NP	NN	B-DNA	20	NMOD	B-DNA
T18	I-Entity	1010	1018	promoter	promoter	I-NP	NN	I-DNA	17	PMOD	I-DNA
O	O	1018	1019	,	,	O	,	O	17	P	O
O	O	1020	1026	rather	rather	B-PP	RB	O	17	PMOD	O
O	O	1027	1031	than	than	I-PP	IN	O	22	DEP	O
O	O	1032	1036	from	from	B-PP	IN	O	17	PMOD	O
O	O	1037	1040	the	the	B-NP	DT	O	29	NMOD	O
T19	B-Entity	1041	1043	Cp	Cp	I-NP	NN	B-DNA	29	NMOD	B-DNA
T19	I-Entity	1043	1044	/	/	B-NP	SYM	I-DNA	29	NMOD	I-DNA
T19	I-Entity	1044	1046	Wp	Wp	I-NP	NN	I-DNA	29	NMOD	I-DNA
T19	I-Entity	1047	1055	promoter	promoter	I-NP	NN	I-DNA	24	PMOD	I-DNA
O	O	1056	1061	which	which	B-NP	WDT	O	29	NMOD	O
O	O	1062	1064	is	be	B-VP	VBZ	O	30	SBAR	O
O	O	1065	1069	used	use	I-VP	VBN	O	31	VC	O
O	O	1070	1072	in	in	B-PP	IN	O	32	VMOD	O
O	O	1073	1081	latently	latently	B-NP	RB	B-cell_type	37	NMOD	B-cell_type
O	O	1082	1090	infected	infected	I-NP	JJ	I-cell_type	37	NMOD	I-cell_type
O	O	1091	1092	B	B	I-NP	NN	I-cell_type	37	NMOD	I-cell_type
O	O	1093	1098	cells	cell	I-NP	NNS	I-cell_type	33	PMOD	I-cell_type
O	O	1098	1099	.	.	O	.	O	5	P	O

O	O	1100	1111	Transcripts	Transcript	B-NP	NNS	O	14	SUB	O
O	O	1112	1120	encoding	encode	B-VP	VBG	O	1	NMOD	O
T10	B-Protein	1121	1126	gp350	gp350	B-NP	NN	B-protein	10	NMOD	B-protein
T10	I-Protein	1126	1127	/	/	O	SYM	O	3	NMOD	O
T10	I-Protein	1127	1130	220	220	B-NP	CD	O	4	AMOD	O
O	O	1130	1131	,	,	O	,	O	10	P	O
O	O	1132	1135	the	the	B-NP	DT	O	10	NMOD	O
O	O	1136	1141	major	major	I-NP	JJ	B-protein	10	NMOD	B-protein
O	O	1142	1146	coat	coat	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	1147	1154	protein	protein	I-NP	NN	I-protein	2	OBJ	I-protein
O	O	1155	1157	of	of	B-PP	IN	O	10	NMOD	O
O	O	1158	1161	EBV	EBV	B-NP	NN	O	11	PMOD	O
O	O	1161	1162	,	,	O	,	O	1	P	O
O	O	1163	1167	were	be	B-VP	VBD	O	19	VMOD	O
O	O	1168	1178	identified	identify	I-VP	VBN	O	14	VC	O
O	O	1178	1179	,	,	O	,	O	19	P	O
O	O	1180	1183	but	but	O	CC	O	19	VMOD	O
O	O	1184	1186	we	we	B-NP	PRP	O	19	SUB	O
O	O	1187	1190	did	do	B-VP	VBD	O	0	ROOT	O
O	O	1191	1194	not	not	I-VP	RB	O	19	VMOD	O
O	O	1195	1199	find	find	I-VP	VB	O	19	VC	O
O	O	1200	1203	any	any	B-NP	DT	O	23	NMOD	O
O	O	1204	1212	evidence	evidence	I-NP	NN	O	21	OBJ	O
O	O	1213	1215	of	of	B-PP	IN	O	23	NMOD	O
O	O	1216	1229	transcription	transcription	B-NP	NN	O	24	PMOD	O
O	O	1230	1234	from	from	B-PP	IN	O	25	NMOD	O
O	O	1235	1238	the	the	B-NP	DT	O	35	NMOD	O
T11	B-Protein	1239	1242	LMP	LMP	I-NP	NN	B-protein	35	NMOD	B-protein
T11	I-Protein	1242	1243	-	-	B-NP	HYPH	O	35	P	O
T11	I-Protein	1243	1245	2A	2A	I-NP	NN	O	35	NMOD	O
O	O	1246	1248	or	or	I-NP	CC	O	35	NMOD	O
T12	B-Protein	1249	1253	EBER	EBER	I-NP	NN	B-DNA	35	NMOD	B-DNA
T12	I-Protein	1253	1254	-	-	B-NP	HYPH	I-DNA	35	NMOD	I-DNA
T12	I-Protein	1254	1255	1	1	I-NP	CD	I-DNA	35	NMOD	I-DNA
T20	B-Entity	1256	1260	loci	locus	I-NP	NNS	I-DNA	26	PMOD	I-DNA
O	O	1261	1263	in	in	B-PP	IN	O	25	NMOD	O
O	O	1264	1272	infected	infected	B-NP	JJ	O	38	NMOD	O
O	O	1273	1283	thymocytes	thymocyte	I-NP	NNS	B-cell_type	36	PMOD	B-cell_type
O	O	1283	1284	.	.	O	.	O	19	P	O

O	O	1285	1290	These	These	B-NP	DT	O	2	NMOD	O
O	O	1291	1303	observations	observation	I-NP	NNS	O	3	SUB	O
O	O	1304	1311	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1312	1316	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1317	1319	de	de	B-NP	FW	O	6	AMOD	O
O	O	1320	1324	novo	novo	I-NP	FW	O	8	NMOD	O
O	O	1325	1328	EBV	EBV	I-NP	NN	O	8	NMOD	O
O	O	1329	1338	infection	infection	I-NP	NN	O	11	SUB	O
O	O	1339	1341	of	of	B-PP	IN	O	8	NMOD	O
O	O	1342	1352	thymocytes	thymocyte	B-NP	NNS	B-cell_type	9	PMOD	B-cell_type
O	O	1353	1360	differs	differ	B-VP	VBZ	O	4	SBAR	O
O	O	1361	1365	from	from	B-PP	IN	O	11	VMOD	O
O	O	1366	1375	infection	infection	B-NP	NN	O	12	PMOD	O
O	O	1376	1378	of	of	B-PP	IN	O	13	NMOD	O
O	O	1379	1380	B	B	B-NP	NN	B-cell_type	16	NMOD	B-cell_type
O	O	1381	1386	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	1386	1387	.	.	O	.	O	3	P	O

O	O	1388	1391	The	The	B-NP	DT	O	3	NMOD	O
O	O	1392	1396	main	main	I-NP	JJ	O	3	NMOD	O
O	O	1397	1407	difference	difference	I-NP	NN	O	4	SUB	O
O	O	1408	1410	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1411	1415	that	that	B-SBAR	IN	O	4	PRD	O
O	O	1416	1420	with	with	B-PP	IN	O	11	VMOD	O
O	O	1421	1431	thymocytes	thymocyte	B-NP	NNS	B-cell_type	6	PMOD	B-cell_type
O	O	1431	1432	,	,	O	,	O	11	P	O
O	O	1433	1435	no	no	B-NP	DT	O	10	NMOD	O
O	O	1436	1444	evidence	evidence	I-NP	NN	O	11	SUB	O
O	O	1445	1450	could	could	B-VP	MD	O	5	SBAR	O
O	O	1451	1453	be	be	I-VP	VB	O	11	VC	O
O	O	1454	1459	found	find	I-VP	VBN	O	12	VC	O
O	O	1460	1464	that	that	B-SBAR	IN	O	13	VMOD	O
O	O	1465	1468	the	the	B-NP	DT	O	16	NMOD	O
O	O	1469	1474	virus	virus	I-NP	NN	O	18	SUB	O
O	O	1475	1479	ever	ever	B-ADVP	RB	O	18	VMOD	O
O	O	1480	1492	circularizes	circularize	B-VP	VBZ	O	14	SBAR	O
O	O	1492	1493	.	.	O	.	O	4	P	O

O	O	1494	1500	Rather	Rather	B-ADVP	RB	O	4	VMOD	O
O	O	1500	1501	,	,	O	,	O	4	P	O
O	O	1502	1505	EBV	EBV	B-NP	NN	O	4	SUB	O
O	O	1506	1513	remains	remain	B-VP	VBZ	O	0	ROOT	O
O	O	1514	1516	in	in	B-PP	IN	O	4	VMOD	O
O	O	1517	1518	a	a	B-NP	DT	O	8	NMOD	O
O	O	1519	1525	linear	linear	I-NP	JJ	O	8	NMOD	O
O	O	1526	1539	configuration	configuration	I-NP	NN	O	5	PMOD	O
O	O	1540	1544	from	from	B-PP	IN	O	8	NMOD	O
O	O	1545	1550	which	which	B-NP	WDT	O	9	PMOD	O
T21	B-Entity	1551	1562	replicative	replicative	B-NP	JJ	B-DNA	12	NMOD	B-DNA
T21	I-Entity	1563	1568	genes	gene	I-NP	NNS	I-DNA	13	SUB	I-DNA
O	O	1569	1572	are	be	B-VP	VBP	O	9	SBAR	O
O	O	1573	1584	transcribed	transcribe	I-VP	VBN	O	13	VC	O
O	O	1584	1585	.	.	O	.	O	4	P	O
